We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
- Authors
Westermann, J.; Nguyen-Hoai, T.; Mollweide, A.; Richter, C.; Schmetzer, O.; Kim, H.-J.; Blankenstein, Th; Dörken, B.; Pezzutto, A.
- Abstract
Since transfection of dendritic cells (DC) plays a key role in DNA vaccination, in vivo expansion of DC might be a tool to increase vaccine efficacy. We asked whether Fms-like tyrosine kinase-3 ligand (Flt-3L), a growth factor for DC, can be used as an adjuvant for DNA vaccination. Beta-galactosidase (ß-gal) was used as a model antigen in C57BL/6 mice. Mice were immunized i.m. with DNA coding for ß-gal with or without additional injection of Flt-3L. In both cases, antigen-specific CD4+ and CD8+ T cells were detectable after vaccination. Compared with DNA alone, additional administration of Flt-3L led to a significant increase in the antigen-specific proliferative response. However, increased cytotoxicity by T cells was not observed. The cytokines secreted by splenocytes of immunized mice upon in vitro stimulation with antigen had a TH2 profile. Humoral responses against ß-gal preferentially consisted of IgG1 antibodies. Analysis of DC from Flt-3L-treated mice revealed an immature phenotype with low or absent expression levels of CD80, CD86 and CD40. We conclude that Flt-3L does not generally skew immune responses towards a TH1 type. More likely, factors determined by the antigen and/or the vaccination procedure itself are crucial for the resulting type of immune response. Flt-3L - under circumstances such as the one we have investigated - can also lead to suppression of TH1 T cell immunity, possibly by expansion of immature/unactivated DC.Gene Therapy (2004) 11, 1048-1056. doi:10.1038/sj.gt.3302261 Published online 15 April 2004
- Subjects
DENDRITIC cells; ANTIGEN presenting cells; VACCINATION; DNA; CYTOKINES; IMMUNE response; IMMUNIZATION; GENETICS of virus diseases
- Publication
Gene Therapy, 2004, Vol 11, Issue 13, p1048
- ISSN
0969-7128
- Publication type
Article
- DOI
10.1038/sj.gt.3302261